The QualityStocks Daily Thursday, October 10th, 2019

Today's Top 3 Investment Newsletters

StockRockandRoll (CLTH) +723.08%

MarketClub Analysis (RARX) +101.10%

QualityStocks (BMXC) +60.00%

The QualityStocks Daily Stock List

Aurania Resources Ltd. (AUIAF)

Metals News, Finance Recorder, The Gold Telegraph, Triple H Stocks, Junior Mining Network, Dividend Investor, Northern Miner, Geology for Investors, Wallet Investor, Stockhouse, Gold Stock Data, TradingView, Investors Hangout, and Market Screener reported previously on Aurania Resources Ltd. (AUIAF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Aurania Resources Ltd. engages in the identification, evaluation, acquisition, and exploration of mineral property interests. A junior mineral exploration company, its focus is on precious metals and copper. The Company’s flagship asset is The Lost Cities – Cutucu Project. This Project is in the Jurassic Metallogenic Belt in the eastern foothills of the Andes mountain range of southeastern Ecuador. Aurania Resources is based in Toronto, Ontario. The Company lists on the OTC Markets Group’s OTCQB.

In addition, Aurania Resources has properties in Canton Valais, Switzerland – Siviez (Uranium, Copper and Gold); Marécottes (Uranium); and Mont Chemin (Gold). All are 100 percent held through Aurania Resources’ wholly owned subsidiary AuroVallis SARL.

The Cordillera del Condor – the eastern foothills to the Andes in southeastern Ecuador – hosts a well-endowed mineral belt. It contains 26 million ounces (Moz) of gold and almost 40 billion pounds (Blbs) of copper in NI-43-101 resources held by different companies. The Lost Cities – Cutucu Project lies along-trend of that mineral belt. Thus, Aurania Resources’ exploration is focused on finding the same types of deposits that occur in the Cordillera del Condor.

Concerning the Switzerland Projects, the Company made formal application in 2015 to obtain new five-year permits for its Swiss projects. Aurania was advised that the Canton Authority (the Ministry) intended to revise the Swiss Mining Law before issuing new permits. The applications were deemed legally “frozen”. As such, Aurania believes all rights, title and interest under the permits, have been preserved. To June 30, 2018, Company Management is unaware of any change in the status of the permits.

Aurania Resources announced this past summer that the stream sediment sampling program that has now been completed over 50 percent of the Lost Cities - Cutucu Project in southeastern Ecuador, identified 17 "epithermal" targets for gold and silver. The latest addition to the target list is "Apai". This is an epithermal target near the southern boundary of the Project. The Apai target comprises several networks of streams that contain elevated concentrations of pathfinder elements - naturally-occurring arsenic and antimony, among others - that typically occur in haloes that enclose epithermal gold-silver systems.

Last month, Aurania Resources reported that follow-up exploration is defining additional, extensive epithermal targets for gold and silver at the Tiria target area on the flanks of a 15 kilometer (km) trend of silver-zinc-lead mineralization at its Lost Cities - Cutucu Project. The Tiria epithermal target was originally described as 'Tiria East' and 'Tiria West'. Aurania has now identified four separate targets within the extensive Tiria target area. These targets lie on the margins of a core of silver-zinc-lead, providing strong indications of a large mineralized system.

Last week, Aurania Resources reported that diamond drilling equipment has been mobilized to site for the scout drilling on the first of the epithermal targets at Yawi in its Lost Cities - Cutucu Project. Drilling was expected to start early this week. The rig is expected to be on each of the four targets for three to four weeks. The present plan is to drill three to four holes of between 350m and 500m in length on each of the targets.

Aurania Resources Ltd. (AUIAF), closed Thursday's trading session at $1.8984, off by 0.60733%, on 15,221 volume with 29 trades. The average volume for the last 3 months is 5,535 and the stock's 52-week low/high is $1.53418004/$3.04999995.

chart

Celexus, Inc. (CXUS)

Invest Tribune, OTC Markets, TeleTrader, Street Insider, PR Newswire, Investors Hangout, TradingView, Wallet Investor, Dividend Investor, InvestorsHub, Last10k, Stockwatch, Market Screener, Stockopedia, Simply Wall St, Stockhouse, and GlobeNewswire reported earlier on Celexus, Inc. (CXUS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Celexus, Inc. is an acquisition, management and holding company for high-trajectory agritech businesses and farming technologies. The OTCQB-listed Company was formerly known as Telupay International, Inc. As of February 2019, Celexus agreed to acquire HempWave and operate it as a wholly-owned subsidiary. HempWave partners with farmers throughout the nation to grow, cultivate, and harvest commercial-grade hemp plants and seeds to produce medicinal grade cannabidiol (CBD oils) and other hemp by-products.

Celexus operates as an acquisition, management, and holding company for early stage businesses and technologies in the hemp industry. The Company works to bring to market the best, most valuable innovations in the thriving industrial hemp space. Celexus is actively assessing new acquisition candidates across the agriculture industry. The Company’s objective is to control every aspect of the farming industry. This is from seeds to extraction and distribution. This eliminates reliance on third parties and ensures premier quality processes and production.

HempWave announced this past June that it acquired all five of the industrial hemp licenses available from the State of Arizona. This is licensure that makes HempWave one of the first vertically integrated hemp companies in Arizona. HempWave physically acquired each of the five respective commercial hemp licenses from Arizona - Nursery, Grower, Harvester, Transporter, and Processor - on May 31, 2019, the first day the licenses were available.

HempWave also announced in June that it entered into agreements with four large-scale farming operations in Arizona. The agreements will permit the Company to grow and harvest industrial hemp on more than 600 acres this year. HempWave's four initial commercial hemp farms will be based in Arizona's Gila River Valley, as well as in the cities of Eloy and Willcox.

HempWave estimates that it will produce 2.1 million pounds of hemp biomass in 2019 alone. This is based upon the new growing and harvesting agreements, and also HempWave’s previously announced acquisition of two Arizona-based greenhouses totaling 210,000 square feet of space for commercial hemp nursery operations.

This past August, HempWave announced that it initiated planting its first fields in Arizona in partnership with industrial farms. The planting marks the first of numerous successful joint ventures (JVs) for HempWave with Arizona farms transitioning to industrial hemp. HempWave partners with farms under a JV Program giving farms access to benefits. These include HempWave’s state-by-state licensing, an established supply chain, and industry-specific expertise in agronomy and horticulture.

Celexus and HempWave announced recently a partnership with Sucseed to support co-working/co-growing greenhouse opportunities. Sucseed is a division of Central Business Development. It is a California-based industrial hemp incubator and accelerator. Its unique and customizable model enables individuals and companies to lease space from “grow tables” in a cooperative greenhouse or entire greenhouse sections for larger full-term grows. HempWave equips Sucseed and its clients with expert support on everything from financial analysis tools and planning to hands-on assistance in growing operations within the greenhouses from HempWave’s master growers.

Celexus, Inc. (CXUS), closed Thursday's trading session at $0.75, even for the day, on 212 volume with 3 trades. The average volume for the last 3 months is 2,409 and the stock's 52-week low/high is $0.188999995/$1.95299994.

chart

Full Alliance Group, Inc. (FAGI)

Penny Stock Base, Stock Scores, TipRanks, Market Screener, StockAP, Insider Financial, StockInvest.us, Morningstar, Stockhouse, Stockwatch, GuruFocus, Clay Trader, 4-Traders, Investors Hangout, Dividend Investor, GlobeNewswire, and InvestorsHub reported earlier on Full Alliance Group, Inc. (FAGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Full Alliance Group, Inc. is a multi-faceted holding company listed on the OTC Markets. It has various interests in technology, healthcare, and nutraceuticals. Nutra Yu, Inc. is a wholly owned subsidiary of Full Alliance Group. EBO2, Inc., is also a wholly owned subsidiary of the Company. Full Alliance Group has its corporate headquarters in Palm Desert, California.

The Company’s Nutra Yu subsidiary develops, markets, and distributes a proprietary line of nutraceutical products. The EBO2 subsidiary is the provider of ''EBO2'', a modern high volume blood gas exchange unit for the treatment of 5-7 liters of blood with medical ozone. The unit allows extracorporeal blood and oxygenation and ozone exposure and blood filtration through the filter in an innovative way by using the integrated diffusing membranes within the filter fibers to trap lipids and proteins that are in excess in the venous blood supply.

The EBO2 unit is considered the world's most advanced medical ozone therapy performed today. The EBO2 procedure is a minimally invasive intravenous therapy alike to hemodialysis developed as a treatment for numerous cardiological problems, allowing the patient to avoid life threatening, highly risky, painful, costly and complicated surgeries and long recovery periods.

Full Alliance Group’s mission is to provide technologically advanced, natural, nutritional products of unrivaled formulation, and also to educate consumers and healthcare practitioners in preventative healthcare and in bio-energetic systems for integrating overall wellness. The Company’s industries include Health & Wellness, Orthomolecular Medicine, Cardiovascular Health, Traditional Chinese Medicine (TCM), Nutraceuticals, and Quantum Energetic Medicine.

This past May, Full Alliance Group announced that Nutra Yu launched new sales and marketing initiatives for its Dr. Louie Yu Formulations™ brand of proprietary nutraceutical products on several online retail platforms. Nutra Yu, Inc. was founded by Dr. Yu to further develop, market, and distribute his proprietary line of nutraceuticals. Nutra Yu's "Dr. Louie Yu Formulations" are a complete product line of inventive all-natural nutraceuticals founded on the science of Traditional Chinese Medicine (TCM), Western orthomolecular concepts, as well as modern-day physics.

Last month, Full Alliance Group announced it appointed Matthew Cook, MD, and Dr. Leonid Macheret to its Medical Advisory Board. Dr. Cook is the Founder of BioReset Medical Corporation and as acting President, operates a Regenerative Medicine and Pain Medicine practice, which provides pioneering non-surgical solutions in orthopedic medicine, sports medicine, regenerative pain medicine, and stem cell medicine.

Dr. Macheret is the Medical Director of Partners In Wellness, Inc. This is an innovative healthcare environment combining holistic healing with today's conventional medical practices. Partners In Wellness specializes in treating chronic illness and pain, fibromyalgia, chronic fatigue syndrome (CFS), nutrition, and non-surgical joint regeneration.

Full Alliance Group, Inc. (FAGI), closed Thursday's trading session at $0.04, up 60.00%, on 3,139,065 volume with 174 trades. The average volume for the last 3 months is 92,632 and the stock's 52-week low/high is $0.00455/$0.057999998.

chart

NervGen Pharma Corp. (NGENF)

Stock Target Advisor, InvestorX, PR Newswire, Market Screener, Investor Ideas, Investors Hangout, Stockhouse, MarketWatch, Wallet Investor, Trading View, and Morningstar reported previously on NervGen Pharma Corp. (NGENF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

NervGen Pharma Corp. is a regenerative medicine company listed on the OTC Markets Group’s OTCQX. Its commitment is to creating ground-breaking solutions for the treatment of nerve damage. This includes spinal cord and peripheral nerve injury. The Company’s lead compound is NVG-291. NervGen Pharma is headquartered in Vancouver, British Columbia.

NervGen’s core technology targets protein tyrosine phosphatase sigma (PTPσ). This is a neural receptor that impedes nerve regeneration. Inhibition of the PTPσ receptor has been shown to promote regeneration of damaged nerves and improvement of nerve function in animal models for different medical conditions. Research has been conducted on other applications of PTPs including MS (Multiple Sclerosis), stroke, cardiac arrhythmia, and Alzheimer’s Disease.

In addition, the Company continues to research secondary applications such as multiple sclerosis, acute myocardial infarction induced arrhythmia (AMI, commonly known as a heart attack), stroke and other neurodegenerative diseases.

NervGen Pharma’s plan is to begin a Phase 1 human clinical trial for its lead compound, NVG-291, in early 2020 under an Investigational New Drug application with the US Food and Drug Administration (FDA). The Company is advancing NVG-291 for the treatment of spinal cord injury as it believes this indication is a significant opportunity due to the present lack of non-surgical solutions in the market, the substantial impact on quality of life, and the high cost burden to the healthcare system.

NervGen’s belief is that NVG-291 as a therapy could alleviate or improve upon the symptoms and conditions associated with spinal cord injury. Furthermore, it believes that NVG-291 as a therapy could empower these patients to live more active and productive lives.

In September, NervGen Pharma announced the clinical development strategy for its compound, NVG-291, in two lead indications: spinal cord injury and MS. The Phase 1 safety and pharmacokinetic study in healthy subjects presently remains on course to start in Q1 of 2020 as originally scheduled. A cohort of spinal cord injury patients, an expansion of NervGen's Phase 1 trial, is scheduled to begin in the second half of 2020. A Phase 2 MS trial is scheduled to begin in Q1 of 2021.

NervGen Pharma Corp. (NGENF), closed Thursday's trading session at $0.98, even for the day, on 5,001 volume with 7 trades. The average volume for the last 3 months is 6,579 and the stock's 52-week low/high is $0.648800015/$1.52499997.

chart

Parallax Health Sciences, Inc. (PRLX)

Proactive Investors, Market Screener, Last10k, Wallmine, Simply Wall St, Wallet Investor, Stockwatch, TMXmoney, 4-Traders, PR Newswire, TradingView, GlobeNewswire, InvestorsHub, and Stockhouse reported previously on Parallax Health Sciences, Inc. (PRLX), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Parallax Health Sciences, Inc. is an outcome-driven connected healthcare company based in Santa Monica, California. It allows for cost-effective remote diagnosis, treatment and monitoring of patients through proprietary platforms of integrated products and services. The Company’s products and offerings capitalize on the digital transformation in healthcare for improved patient compliance, diagnosis and treatment, and support healthcare system cost savings and efficiencies. Parallax Health Sciences’ shares trade on the OTC Markets’ OTCQB.

Parallax centers on personalized patient healthcare by way of its wholly owned subsidiaries, Parallax Health Management, Parallax Behavioral Health, and Parallax Diagnostics. The Company’s interoperable novel applications provide patients point-of-care testing and monitoring with information communicated via internet-based mobile phone applications that are agnostic as to operating system. They are constructed on highly sophisticated data analytics.

Information is retrieved real-time by physicians who are monitoring patients with chronic diseases or through biometric feedback for health-related behavior modification. Information is automated for integration into electronic health records.

Concerning Parallax Diagnostics, Parallax's Target Antigen Detection System (TADS) Diagnostic Platform is a Controlled Flow-Through Rapid Immunoassay Technology. It offers an array of improved modifications and features to the traditional Flow-Through Immunoassay Test. With its Platform uniformity, vacuum pump, absorption layer for sample overflow, and complete compatibility with the Company’s optic reader, the Target System Diagnostics Platform is a unique collection of tests for qualitative and quantitative detection of patient conditions.

Parallax Health Management provides remote monitoring solutions. These solutions are to support disease management and provide better care options for chronic conditions.

Parallax Behavioral Health (PBH) provides consulting and software solutions to businesses and individuals. This is to improve value, margin, and performance via enhanced outcomes and lower cost mastery. PBH has its patented Intrinsic Code. It includes predictive-progressive analytics and goal optimization software. PBH is strategically positioned to enable users from large healthcare corporations to individuals take control of their outcomes.

In September, Parallax Health Sciences announced it entered into a strategic transaction agreement with Global Career Networks, Inc., (GCN). GCN is a provider of career solutions to one of the largest recruiter networks globally with exposure to more than one-half million recruiters and millions of C-level executives. The Company is purchasing a 19 percent stake in GCN. This strategic transaction opens access to a large population for providing Cognitive outcomes optimization of the Company’s Good Health Outcomes platform for the healthcare market.

Parallax Health Sciences, Inc. (PRLX), closed Thursday's trading session at $0.0999, even for the day, on 20 volume. The average volume for the last 3 months is 70,389 and the stock's 52-week low/high is $0.054000001/$0.279900014.

chart

Pilot Bancshares, Inc. (PLBN)

Penny Stock Hub, TipRanks, PR Newswire, Nasdaq, GuruFocus, Wallet Investor, TradingView, Dividend Investor, Stockopedia, Market Screener, Investors Hangout, Biz Journals, and Morningstar reported beforehand on Pilot Bancshares, Inc. (PLBN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Pilot Bancshares, Inc. operates as the bank holding company for Pilot Bank. The Bank provides retail, commercial, and investment services to individuals, businesses, and institutions in the greater Tampa Bay and Lakeland, Florida areas. Pilot Bank was Chartered by the State of Florida in 1987. The Bank’s holding company, Pilot Bancshares, Inc. was established in October 1995. Pilot Bancshares lists on the OTC Markets’ OTCQX. A Florida corporation, the Company has its corporate office in Tampa, Florida.

Pilot Bancshares’ main holdings are National Aircraft Finance Company (NAFCO) and the above-mentioned Pilot Bank, a state-chartered commercial bank and member of the Federal Reserve System. NAFCO specializes in the origination of owner-flown aircraft loans, most of which are purchased by Pilot Bank.

Pilot Bank’s six financial centers in Tampa Bay are strategically located in South Tampa, New Tampa, Temple Terrace, Upper Tampa Bay, and St. Petersburg. A sixth financial center is located in the Lakeland business district. The design of the Bank’s complete suite of financial products and services is to help customers manage personal and business matters as conveniently as possible. Pilot Bank offers retail and commercial deposit accounts and wide-ranging commercial lending capabilities (including Small Business Administration Loans), and also access to professional investment services.

Personal Banking Services include Personal Checking Accounts, Savings Accounts, Money Market Accounts, and Certificates of Deposit, and Remote Deposits. Personal Banking Services also include Personal Online Banking, Health Savings Accounts, as well as Consumer Loans.

Pilot Bank also offers home equity and consumer loans; commercial real estate mortgages, term loans, equipment financing, working capital lines of credit, small business administration loans, and business credit cards. It also offers construction and permanent financing for income producing properties, and lines of credit for builders. Furthermore, the Bank provides treasury management and merchant services; aircraft financing; investment services; as well as online banking services. Pilot Bank holds a five-star Bauer rating.

This past June, OTC Markets Group announced that Pilot Bancshares, Inc. qualified to trade on the OTCQX® Best Market. Pilot Bancshares upgraded to OTCQX from the Pink® market.

Pilot Bancshares, Inc. (PLBN), closed Thursday's trading session at $3.45, up 0.877193%, on 1,300 volume with 3 trades. The average volume for the last 3 months is 14,510 and the stock's 52-week low/high is $2.90000009/$3.69000005.

chart

Two Rivers Water & Farming Company (TURV)

Green Rush Review, Transparent Traders, Investor Village, Zacks, Stocks Newswire, Daily Marijuana Observer, TipRanks, Market Screener, OTC Markets, GuruFocus, Insider Financial, Last10k, Wallet Investor, TMXmoney, The Marijuana Investor, Simply Wall St, GlobeNewswire, Stockhouse, Nasdaq, Morningstar, InvestorsHub, TradingView, and Investing.com reported beforehand on Two Rivers Water & Farming Company (TURV), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Two Rivers Water & Farming Company is a vertically integrated agricultural, water rights, and consumer products company. It is pursuing a mission to become a foremost hemp-based seed-to-sale operator. It owns agricultural land and water rights in Southern Colorado where it grows diverse strains of hemp with proprietary genetics. The Company’s land and water assets include greater than 2,500 acres of agricultural land and more than 1,500 square miles of drain water rights. Two Rivers Water & Farming Company (TURV) is based in Aurora, Colorado.

The Company has a brand portfolio of premium natural supplements. This includes CBD (cannabidiol). Via its consumer brand subsidiary, Gramz LLC, it develops leading products in various categories, including CBD. Furthermore, TURV has operational expertise in hemp production and distribution. Its subsidiary is Vaxa Global. Vaxa’s management team has decades of experience in agricultural operations. This includes hemp production and manufacturing.

TURV is positioned to grow different strains of hemp with proprietary genetics, to sell bulk biomass, process and extract phyto-cannabinoids and to develop and distribute consumer products. The Company plans to monetize its varied asset base of land and water through recently acquired hemp companies to form an integrated seed-to-sale enterprise.

Last month, TURV announced that its wholly owned subsidiary, Vaxa Global, LLC, reached agreements with Montverde Partners, LLC to acquire extraction equipment, seeds and clones inventory and full ownership of the 2019 hemp crop from the Butte Valley farm. Monteverde is a joint venture (JV) partner of Vaxa in the Butte Valley hemp farming operation near Walsenburg, Colorado.

The agreements call for Vaxa Global to take ownership of more than $900,000 in extraction and processing equipment purchased by Montverde since 2017. Furthermore, Montverde will transfer the full ownership of the 2019 hemp crop in Butte Valley farm that is expected to be harvested this month, along with the full seed and clone inventory of Montverde that will be recognized in TURV’s inventory during Q4 after the harvest.

Last week, TURV announced its forecast for the hemp crop planted on the Butte Valley Farm in Huerfano County, Colorado. The crop comprises about 15 acres. The expectation is that it will be ready to harvest during the first or second week in November. The yield on the crop is expected to adequately supply the hemp requirements for the internal Gramz whole-plant based consumer brand line and the specialty smokable line, Cannasmokes.

After the harvest, TURV expects to have sufficient seedlings for a full planting on the 158-acre existing farm in Butte Valley. The Company has started a propagation facility in Springfield, Colorado to grow additional seedlings for 2020. TURV is planning to share crop the remaining irrigated 300-plus acres next season.

Two Rivers Water & Farming Company (TURV), closed Thursday's trading session at $0.25, even for the day, on 71,669 volume with 24 trades. The average volume for the last 3 months is 255,140 and the stock's 52-week low/high is $0.079999998/$0.735000014.

chart

Alpine 4 Technologies  Ltd. (ALPP)

Stockhouse, MarketWatch, Proactive Investors, Investors Hangout, Uptick Newswire, Wallet Investor, GuruFocus, TradingView, InvestorsHub, OTC Markets, Barchart, Market Screener, Financial Content, Investor Place, and Capital Cube reported earlier on Alpine 4 Technologies  Ltd. (ALPP), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.  

Alpine 4 Technologies Ltd. is  a  technology and manufacturing holding company. It has business-related endeavors in Automotive Technologies, Electronics Manufacturing, Software and Data Technologies. Established in 2014, Alpine 4 Technologies has its corporate headquarters in Phoenix, Arizona. The Company lists on the OTC Markets’ OTCQB.

Alpine 4’s’s subsidiaries and product groups include ALTIA;  Quality Circuit Assembly (QCA); and Venture West Energy Services. ALTIA is an automotive products company. The Quality Circuit Assembly (QCA) subsidiary  provides electronic contract manufacturing solutions delivered to its customers through strategic business partnerships. Venture West Energy Services centers on supporting the oil and gas industry in Texas, Oklahoma, and Arkansas.

The Company’s focus is on how the adaptation of new technologies, even in brick and mortar businesses, can increase innovation. The core of its acquisition strategy is its emphasis on existing smaller middle market operating companies with Revenues of $5 to $50 million. 

The design of Alpine 4 Technologies is to allow its subsidiaries room to develop their own identities and synergistically prosper from inter-company resources and collaboration. Alpine 4 will own controlling interest in every subsidiary. Moreover, it will also have direct control over planning and management. 

Alpine 4 Technologies completed its acquisition of American Precision Fabricators, Inc. (APF) in 2018. The acquisition adds to Alpine 4’s technology manufacturing sector play, which started in 2016 with its purchase of Quality Circuit Assembly (QCA). This is the fourth acquisition that Alpine 4 Technologies has made in two years.

Last month, Alpine 4 Technologies announced that it concluded its beta pilots of SPECTRUMebos. This is a blockchain Enterprise Business Operating System that it started developing in 2017. The Company anticipates moving those pilot sessions to full production in Q1 2019 with its subsidiaries: Quality Circuit Assembly and American Precision Fabricators.

SPECTRUMebos is an Enterprise Business Operating System (EBOS) developed by Alpine 4 Technologies. It combines the key technology software components of Accounting and Financial Reporting with that of an Enterprise Resource Planning System (ERP), a Document Management System (DMS), a Business Intelligence (BI) platform and a Customer Resource Management (CRM) hub that are all tied to a management reporting and collaboration toolset.

Alpine 4 Technologies continued with its DSF acquisition strategy last week with the announcement that it completed the acquisition of Morris Sheet Metal, Corp. and JT Spiral (MSM). Alpine 4 took effective control of the companies on January 1, 2019. The acquisitions are the first for Alpine 4's construction services holdings portfolio.

Morris Sheet Metal and JT Spiral were formed in 1992. They primarily service large industrial clients in the food manufacturing industry. Their services include design, fabrication and installation of dust collectors, commercial ductwork, kitchen hoods, industrial ventilation systems, machine guards, architectural work, water furnaces and much more.

Alpine 4 Technologies  Ltd. (ALPP), closed Thursday's trading session at $0.0225, up 32.3529%, on 9,957,110 volume with 468 trades. The average volume for the last 3 months is 2,380,818 and the stock's 52-week low/high is $0.005599999/$0.104999996.

chart

Greystone Logistics, Inc. (GLGI)

Zacks, Wallet Investor, MicroCapClub, Market Screener, Real Investment Advice, Marketwired, Corporate Information, YCharts, Equity Clock, Capital Cube, Trading View, Stockhouse, last10k, Stockopedia, InsiderWisdom, GuruFocus, NoNameStocks, Morningstar, Simply Wall St, and MarketWatch reported previously on Greystone Logistics, Inc. (GLGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Greystone Logistics, Inc. reprocesses and sells recycled plastic. In addition, the Company designs, manufactures, sells, and leases high-quality 100 percent recycled plastic pallets. These provide logistical solutions required by a broad variety of industries. These industries include food and beverage, agricultural, automotive, chemical, and pharmaceutical and consumer products.  A "Green" manufacturing and leasing business, Greystone Logistics is headquartered in Tulsa, Oklahoma.

Greystone Logistics is the largest 100 percent recycled plastic pallet manufacturer in the U.S. The Company provides cost advantages over users of virgin resin. The excess plastic not used in the production of pallets undergoes reprocessing for resale.

Greystone’s products include rackable, nestable, display, monoblock, and stackable pallets. Furthermore, its products include picture frame web-top pallets and web-top pallets. The Company also sells recycled plastic that undergoes reprocessing into pellet form. Moreover, Greystone provides pallet leasing services. 

Greystone Logistics offers recycled pallets for sale including full picture frame and three skids models and IBC pallets. Plastic pallets last 10-50 times longer than wood; have trade-in value; are recyclable; have a high coefficient of friction with anti-skid design for top, bottom, and fork lift tine contact; have substantially lower life cycle costs (cost per trip) and are suited for closed loop systems.

Greystone’s technology, including that used in its injection molding equipment, and its proprietary blend of recycled plastic resins and patented pallet designs, enables fast production of high-quality pallets and at lower costs than numerous processes. The recycled plastic for its pallets helps control material costs, while reducing environmental waste.

Recently, Greystone Logistics reported continued record sales for the six months and quarter ended November 30, 2018. Sales for the six months ended November 30, 2018 were $32,939,240 compared to $20,009,177 for the six months ended November 30, 2017 for an increase of $12,930,063. This represents a 65 percent increase.

Greystone Logistics, Inc. (GLGI), closed Thursday's trading session at $0.4439, up 16.8158%, on 5,211 volume with 5 trades. The average volume for the last 3 months is 21,846 and the stock's 52-week low/high is $0.364199995/$0.771000027.

chart

Cannabics Pharmaceuticals, Inc. (CNBX)

TopPennyStockMovers, Promotion Stock Secrets, TheMicrocapNews  Cannabis Financial Network News, Wealth Insider Alert, Wall Street Mover, SmallCapVoice, StreetAuthority Daily, Wall Street Daily, Stockgoodies, and Market Intelligence Center reported earlier on Cannabics Pharmaceuticals, Inc. (CNBX), and we also report on the Company, here at the QualityStocks Daily Newsletter.  

Cannabics Pharmaceuticals, Inc.’s commitment is to the development of advanced cannabinoid-based treatments and therapies. The Company’s primary focus is the development of novel therapies and biotechnological tools designed to provide relief from  diverse ailments and treat human malignancies. Cannabics’ vision is to create individually tailored natural therapies for cancer patients, utilizing advanced screening systems and personalized bioinformatics tools. OTCQB-listed, Cannabics Pharmaceuticals is headquartered in Bethesda, Maryland. 

Cannabics has licensed Research and Development (R&D) based in Israel. This R&D’s dedication is to the development of palliative and personalized  anti-cancer treatments channelling the multipurpose therapeutic values of cannabinoids to create tailored therapies for cancer patients. The Company’s integrated technology has created a successful medically standardized delivery system providing patients natural, reliable, and safe therapy. Cannabics has created a Genetic lab. This lab will develop diagnostic tools based on human genome, tumor genetics, and cannabinoids.

The Company’s advanced tools include novel delivery systems, personalized medicine diagnostics, as well as therapies based on cannabinoid compounds. Cannabics’ main technology is Cannabics SR. This technology is for a long acting oil capsule that provides a safe, effective, and reliable administration of cannabis. The technology’s composition is exclusively from food grade materials.

Cannabics Pharmaceuticals announced in August 2018 a partnership agreement with Eroll Grow Tech ltd (Seedo), developer of the world's first fully-automated grow device designed specifically for cannabis. Through this new partnership, Cannabics Pharmaceuticals and Seedo will develop the first controlled device for growing medical cannabis at home, ensuring sustainable quality and supply of natural, pesticide free product.

Recently, Cannabics Pharmaceuticals announced the results of its pilot study to test the efficacy of Cannabics capsules for the treatment of cancer anorexia-cachexia syndrome (CACS) in advanced cancer patients. Preliminary findings showed that all patients who were involved in the study for the first four and a half months reported an increase in appetite, and also 83 percent of all those that completed the study.

Moreover, results demonstrated a weight increase of greater than 10 percent for 60 percent of the patients who completed the study. The remaining patients had a stable weight. Additionally, 50 percent of the patients who completed the study reported pain reduction and sleep improvement.

Recently, Cannabics Pharmaceuticals announced it filed a provisional patent application with the US Patent Office. The patent covers Cannabics’ novel drug targeting technology accustomed to deliver cannabinoid compounds. Employing a magnetic delivery system, the unique non-invasive approach permits external and internal systemic delivery of cannabinoids to the actual area of tumors within the patient.

Cannabics Pharmaceuticals, Inc. (CNBX), closed Thursday's trading session at $0.2342, up 13.3043%, on 118,114 volume with 54 trades. The average volume for the last 3 months is 88,007 and the stock's 52-week low/high is $0.200399994/$0.704999983.

chart

Bemax, Inc. (BMXC)

Penny Investor Network, StockRockandRoll, PennyStockLocks, Penny Stock Tweets, Stock Guru, Insider Financial, and ResearchOTC reported on Bemax, Inc. (BMXC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 2012, Bemax, Inc. is a growing global distributor of Disposable Baby Diapers. The Company exports and distributes Disposable Baby Diapers from the United States to developing markets in Africa and Europe. In addition, it exports its private label brands from manufacturers in Asia and distributes to other growing markets. Listed on the OTCQB, Bemax is based in Dallas, Georgia.

The Company’s commitment is to the marketing, distribution, and delivery of high quality disposable baby diapers and wipes to respective target markets. Its current emphasis is to supply its clients with disposable baby diapers from manufacturers in North America where quality is superior.

Bemax is pursuing opportunities in the fast-growing international Consumer Staples and Household Products Industries. The Company focuses on business development and mentoring. It synergizes these models into the household products industry.

Bemax announced in 2017 that it entered into a multi-year private labeling agreement with North American Diaper Company (NADC). With this agreement, Bemax will buy, sell, export, and distribute Mother's Touch disposable diapers in private labeled format and in Bemax packaging not trademarked by NADC. NADC is a foremost U.S. manufacturer of value-priced, eco-friendly disposable baby diapers.

Bemax announced this past April that it filed for trademark with the U.S. Patent & Trademark Office (USPTO) for its brand of Mother's Touch disposable diapers. The Company officially filed for trademark on April 28, 2018 (Serial Number 87899104).

Bemax previously announced that its private label brands of sanitary pads and baby wipes would be available for sales commencing this month. The new Bemax private label brands are available on Walmart.com and on bemaxinc.com/webstore.

Shipment of the Company’s new private label brands to wholesalers and distributors started last month. Furthermore, Bemax will extend sales of its private label to other online selling platforms including target.com to support and grow online sales.

Bemax, Inc. (BMXC), closed Thursday's trading session at $0.00016, up 60.00%, on 1,500 volume with 1 trade. The average volume for the last 3 months is 624,754 and the stock's 52-week low/high is $0.000099999/$0.0012.

chart

Amarantus Bioscience Holdings, Inc. (AMBS)

Stockopedia, Nasdaq.com, Stockhouse, 4-Traders, Zacks, Streetwise Reports, InvestorsHub, and Insider Financial reported on Amarantus Bioscience Holdings, Inc. (AMBS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Formed in 2008, Amarantus Bioscience Holdings, Inc. is JLABS-alumnus biotechnology holding company. It is developing first-in-class orphan neurologic, regenerative medicine and ophthalmic therapies through its subsidiaries. The Company’s wholly-owned subsidiaries include Elto Pharma, Inc; Cutanogen Corporation, and MANF Therapeutics. Amarantus Bioscience Holdings is based in New York, New York.

Amarantus Bioscience also owns about 79.25 million shares of Avant Diagnostics, Inc. (AVDX) via the sale of its wholly-owned subsidiary Amarantus Diagnostics, Inc. that took place in May 2016.

Amarantus Bioscience is centering on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The Company’s lead therapeutic program is eltoprazine. This is a Phase 2b-ready small molecule indicated for the treatment of Levodopa-induced dyskinesia - one of the most difficult problems facing patients with Parkinson’s disease.

Elto Pharma has development rights to eltoprazine. In addition, eltoprazine is undergoing evaluation for the treatment of adult attention deficit hyperactivity disorder (ADHD) and Alzheimer’s aggression.

The Company’s diagnostics division is Amarantus Diagnostics. Its lead diagnostic product is LymPro Test®. This is a blood-based assay to diagnose Alzheimer’s disease. LymPro Test® is approved for investigational use only to be used in biotechnology and pharmaceutical clinical trials.

Amarantus Diagnostics is also developing MSPrecise®. This is a proprietary, next-generation DNA sequencing (NGS) assay for the identification of patients with relapsing-remitting multiple sclerosis (RRMS) at first clinical presentation.

Amarantus Bioscience’s subsidiary MANF Therapeutics owns key intellectual property (IP) rights and licenses from many prominent universities related to the development of the therapeutic protein called mesencephalic astrocyte-derived neurotrophic factor (MANF). MANF Therapeutics is developing MANF-based products as treatments for brain and ophthalmic disorders.

Also, Amarantus Bioscience acquired the rights to the Engineered Skin Substitute program. This is a regenerative medicine-based approach for treating severe burns with full-thickness autologous skin grown in tissue culture that is being pursued by subsidiary Cutanogen Corporation.

Recently, Amarantus Bioscience announced that based upon its review of the clinical data from a German-based clinical study led by Leipzig University's Dr. Thomas Arendt, it exercised its Exclusive Option with Leipzig to negotiate license rights to Alzheimer's blood diagnostic "LymPro Test 2.0," that compares traditional LymPro Test results with those of amyloid PET imaging for the diagnosis of Alzheimer's disease.

Amarantus Bioscience and Leipzig University agreed to broaden the scope of license negotiations to include additional key markers collected during the clinical study. This includes CSF-tau.

Amarantus Bioscience recently received an independent third-party valuation report that valued the Parkinson's disease levodopa-induced dyskinesia (PD-LID) indication for Eltoprazine in the United States and Europe at $316 million. Company management has outlined two distinct paths for Elto Pharma to get as much value for the Eltoprazine asset for Amarantus Bioscience as possible.

One path is standalone private funding followed by a U.S. or Hong Kong-based IPO. The second path may be a business combination with an established clinical-stage biopharmaceutical company with strong management and a first-rate pipeline in which Amarantus Bioscience could become a major shareholder. Amarantus Bioscience expects to make a final determination on the capital formation plan for Elto Pharma this summer.

Amarantus Bioscience Holdings, Inc. (AMBS), closed Thursday's trading session at $0.014, up 11.6427%, on 379,356 volume with 24 trades. The average volume for the last 3 months is 322,981 and the stock's 52-week low/high is $0.009999999/$0.076499998.

chart

El Capitan Precious Metals, Inc. (ECPN)

HotOTC, StockEgg,  StockRich, TopPennyStockMovers, SmallCapVoice, PennyInvest, CoolPennyStocks,  AllPennyStocks,  PennyTrader Publisher, BullRally, MadPennyStocks, PennyStockVille, and OTCPicks reported on El Capitan Precious Metals, Inc. (ECPN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

El Capitan Precious Metals, Inc. is a mining company based in Scottsdale, Arizona.  It mainly engages in the mining of precious metals and other minerals. The Company chiefly holds interest in the El Capitan gold-silver property situated  close to Capitan, New Mexico, in Lincoln County. El Capitan Precious Metals’ principal asset is its wholly-owned subsidiary El Capitan, Ltd., an Arizona corporation.

The El Capitan, Ltd. subsidiary holds the 100 percent equity interest in the El Capitan property. The Company’s primary objective is the sale of the El Capitan property. 

The El Capitan deposit has been known as a potential iron ore resource for numerous decades. The El Capitan deposit has a near-surface, pervasive nature. All of this takes place above the regional water table. This provides the potential for a low mining cost and a long life operation.

El Capitan Precious Metals owns 3,840 acres of mining property in Lincoln County. This includes 80 acres of patented and 3,760 acres of leased property. These include 188 mining claims. The El Capitan property encompasses 354 Bureau of Land Management (BLM) lode claims and four patented claims.  

El Capitan Precious Metals has enhanced its relationship with Logistica US by way of an agreement under which El Capitan will provide to Logistica concentrated ore to their specifications at the mine site. Logistica will transport, process, as well as refine the precious metals concentrates to sell to precious metals buyers. The agreement is in addition to and complements the previously announced agreement for the sale of iron ore for use in construction. 

In December 2017, El Capitan Precious Metals announced that it entered into an agreement with a refiner that will buy, refine, and sell the hyper-concentrates generated by the pilot plant. Moreover, the Company reported that the refiner has spent a considerable amount of time with its contract miner at the pilot plant and at the mine site.

Recently, El Capitan Precious Metals announced that an agreement was executed in December 2017 for the sale of the Company’s precious metal hyper-concentrates. El Capitan Chairman and Chief Executive Officer, Mr. John F. Stapleton reported that El Capitan reached a final agreement with a buyer and executed a Purchase Agreement for all remaining hyper-concentrates produced by the Pilot Plant from the concentrate materials stored at the bonded warehouse in Tucson, Arizona.

The sale represents the last El Capitan Pilot Program activity. It successfully completes the objectives of the Pilot program. This month, El Capitan Precious Metals reported a breach of contract by the buyer of concentrates. The Company reported that it was informed on March 30, 2018, that the contracted buyer to purchase and process the concentrates from El Capitan Precious Metals decided not to process the material. Instead, the contracted buyer is offering to ship the material back to El Capitan Precious Metals.

El Capitan is investigating the matter. The Company said it will take all necessary and proper steps to pursue civil and criminal litigation of the matter, if appropriate upon further investigation, upon the material being returned. El Capitan Precious Metals will provide further details at the 2018 Shareholder Meeting scheduled for Wednesday, May 23, 2018 in Scottsdale, Arizona.

El Capitan Precious Metals, Inc. (ECPN), closed Thursday's trading session at $0.0141, up 19.4915%, on 25,950 volume with 3 trades. The average volume for the last 3 months is 151,797 and the stock's 52-week low/high is $0.000199999/$0.039599999.

chart

Tonogold Resources, Inc. (TNGL)

PennyFix, 24hGold, StreetInsider, Simply Wall St, InvestorsHub, Stockhouse, 4-Traders, OTC Markets, and WalletInvestor reported on Tonogold Resources, Inc. (TNGL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A leading junior mining company, Tonogold Resources, Inc. concentrates on developing advanced stage projects in the Americas. The Company’s management team has over six decades of combined experience in the mining space. Tonogold Resources’ commitment is to consolidating a 5 Million Gold Oz portfolio in combined resources in the short term as well as reaching production stage on its flag-ship project in the United States.

Tonogold Resources has its head office in La Jolla, California. The Company’s shares trade on the OTC Markets Group’s OTCQB.

In October of 2017, Tonogold Resources announced that it entered into a binding agreement with Comstock Mining, Inc. (LODE), which among other things, provides Tonogold Resources an exclusive right to earn a 51 percent controlling interest in 1,162 acres of mining claims in the highly prospective Comstock Lode area in Virginia City, Nevada. This includes the Lucerne Deposit, positioned in the Storey and Lyon Counties.

In January 2018, Tonogold Resources announced that it entered into a binding agreement with a private Mexican company, which provides Tonogold an exclusive right (but not obligation) to acquire 100 percent interest in the Claudia, Promontorio, and Montoros gold/silver properties in Durango, Mexico for total consideration of $7.3 million in cash.

This acquisition potentially adds high quality gold-silver advanced exploration projects to the Company’s pipeline in a safe and recognized mining-friendly and cost competitive jurisdiction. Highlights of this acquisition also include a low cost option fee and attractive acquisition value per gold equivalent ounce based on the historical resources.

Recently, Tonogold Resources announced that it entered into the second phase of its option agreement with Comstock Mining and recently paid the scheduled $2 million to Comstock, pursuant to the agreement dated October 3, 2017. The decision by Tonogold follows a detailed six-month technical and economic assessment of the Lucerne deposit by the Company’s technical consultants, Mine Development Associates (MDA), of Reno, Nevada, which included the development of a new resource model.

Currently, the resource and preliminary economic pit design work completed by MDA has provided Tonogold Resources with confirmation that the resource at Lucerne is likely to support a technically and economically viable mining operation. However, more data validation and verification will be required before MDA are able to provide Resource and Reserve estimates suitable for production planning and public reporting.

Tonogold Resources, Inc. (TNGL), closed Thursday's trading session at $0.21, up 28.0488%, on 1,100 volume with 2 trades. The average volume for the last 3 months is 18,558 and the stock's 52-week low/high is $0.035/$0.25.

chart

The QualityStocks Company Corner

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (OTCQB: SHRG), a diversified holdings company that owns, operates or controls an interest in an array of companies specializing in the direct-selling industry, is advancing its global expansion strategy. An article discussing the results reads, “‘We are pleased to have our trading symbol changed to better reflect our new name, which more closely aligns with our mission to expand globally,’ Sharing Services CEO John ‘JT’ Thatch stated in a news release (http://nnw.fm/5OYYl). To view the full article, visit http://nnw.fm/1ezpU.

Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services Global Corporation (SHRG), closed Thursday's trading session at $0.175, up 9.375%, on 12,000 volume with 3 trades. The average volume for the last 3 months is 35,959 and the stock's 52-week low/high is $0.090000003/$0.3944.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands, LP (VPRB) was featured today in a publication from CBDWire, examining how CBD products in an array of forms continue to transform the marketplace, surpassing Kim Kardashian, Beyoncé, and veganism in search popularity according to Google data (http://cnw.fm/yt0tU). Also today, the company was highlighted in a publication from HempWireNews looking at the news that lack of hemp seed has led to the closure of a hemp seed processing plant in Vermont, Victory Hemp Food, which used to produce hemp seed oil and hemp flour has either sold its equipment’s or transported them back to Kentucky.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit www.goldlinehemp.com for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed Thursday's trading session at $0.045, up 9.4891%, on 10,892 volume with 11 trades. The average volume for the last 3 months is 141,175 and the stock's 52-week low/high is $0.033799998/$0.119999997.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, has developed a revolutionary CBD processing system, the BaroShear K45, which effectively solves the water solubility issue found in most of today’s oil-based CBD products. To view the full article, visit http://cnw.fm/KZbo6.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Thursday's trading session at $2.75, off by 1.7857%, on 7,089 volume with 18 trades. The average volume for the last 3 months is 9,549 and the stock's 52-week low/high is $1.25/$4.0300002.

Recent News

chart

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced its recognition at the Excellence in Manufacturing Consortium (“EMC”) Awards of Excellence ceremony held on October 9 in Toronto. According to the update, Organigram was honored with an Outstanding Member Contribution Award for delivering exemplary support to the EMC over the course of its membership. To view the full press release, visit http://cnw.fm/4P8aL.

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Thursday's trading session at $2.72, off by 13.6508%, on 3,269,272 volume with 9.575 trades. The average volume for the last 3 months is 1,170,510 and the stock's 52-week low/high is $2.71000003/$8.43999958.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

Digital marketing and consumer-data-management technology company SRAX (NASDAQ: SRAX)has developed the BIGtoken platform, a consumer-managed data marketplace where people can own and earn from their data. An article discussing the company reads, “The platform offers benefits for both customers and marketers. To view the full article, visit http://nnw.fm/gh8C1.

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Thursday's trading session at $2.02, off by 4.717%, on 84,704 volume with 565 trades. The average volume for the last 3 months is 95,343 and the stock's 52-week low/high is $1.54999995/$5.8499999.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was featured today in a publication from CBDWire, examining how in recent years, cannabidiol has become a lot more mainstream than it used to be and the CBD industry is one of the fastest-growing industries in the world. It’s clear that CBD isn’t going anywhere, and entrepreneurs have been flocking to the industry to have a piece of the pie. Every enterprise requires adequate preparation and starting a successful CBD brand isn’t different.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Thursday's trading session at $1.22, off by 6.1538%, on 180,226 volume with 320 trades. The average volume for the last 3 months is 349,939 and the stock's 52-week low/high is $0.843599975/$5.20499992.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a publication from Financialnewsmedia.com, examining how, as the cannabis market booms, another drug may soon follow in its footsteps — psilocybin mushrooms.  Already, we’re seeing a groundswell of interest.  In fact, activists in California are working on getting its decriminalization added to the 2020 ballot.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Thursday's trading session at $0.84, off by 21.1268%, on 4,233,566 volume with 2,577 trades. The average volume for the last 3 months is 820,860 and the stock's 52-week low/high is $0.819000005/$4.75.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Global innovator in drug delivery platforms Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) provided an extensive update on advances in its research and development program with Altria Ventures Inc., an indirect wholly owned subsidiary of Altria Group, Inc (NYSE: MO). The collaboration focuses on the pursuit of reduced risk oral nicotine consumer products using the Lexaria-patented DehydraTECH technology.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hmep-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Thursday's trading session at $0.48, off by 9.434%, on 106,086 volume with 71 trades. The average volume for the last 3 months is 83,741 and the stock's 52-week low/high is $0.399800002/$1.90999996.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (ETST) was featured today in a publication from HempWireNews, examining how lack of hemp seed has led to the closure of a hemp seed processing plant in Vermont, Victory Hemp Food, which used to produce hemp seed oil and hemp flour has either sold its equipment’s or transported them back to Kentucky.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed Thursday's trading session at $0.315, off by 7.3529%, on 30,033 volume with 17 trades. The average volume for the last 3 months is 44,795 and the stock's 52-week low/high is $0.300999999/$1.95000004.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (OTCQB: CIIX), an established financial news and investment portal for the global Chinese-speaking community, recently attended the MicroCap Conference at the Essex House in New York. CIIX subsidiary Biotech CBD Inc. CFO Alex Hamilton gave the company’s presentation (http://cnw.fm/x5iZm). To view the full article, visit http://cnw.fm/2Gpkc.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Thursday's trading session at $0.26, off by 2.9126%, on 33,941 volume with 15 trades. The average volume for the last 3 months is 45,049 and the stock's 52-week low/high is $0.25/$1.04999995.

Recent News

chart

Grapefruit Boulevard Investments Inc. (IGNG)

The QualityStocks Daily Newsletter would like to spotlight Grapefruit Boulevard Investments Inc., the wholly owned subsidiary of Imaging3 Inc. (IGNG).

Grapefruit Boulevard Investments Inc. (IGNG) was featured today in a publication from CBDWire, examining how in recent years, cannabidiol has become a lot more mainstream than it used to be and the CBD industry is one of the fastest-growing industries in the world. It’s clear that CBD isn’t going anywhere, and entrepreneurs have been flocking to the industry to have a piece of the pie. Every enterprise requires adequate preparation, and starting a successful CBD brand isn’t different.

Grapefruit Boulevard Investments Inc., a California corporation (“Grapefruit”), as of May 31, 2019, is a wholly owned subsidiary of Imaging3 Inc. (OTC: IGNG), a Delaware corporation whose shares of $.001 par value common stock are publicly traded on the OTCMarkets OTCQB Market under the symbol “IGNG.” IGNG is subject to the reporting requirements of the Securities Exchange Act of 1934 and files annual and quarterly reports pursuant thereto. Grapefruit holds licenses originally issued by the State of California in January 2018 to both manufacture and distribute cannabis products. Grapefruit’s management now owns a controlling interest in IGNG which now owns 100% of Grapefruit’s outstanding shares. As a result, IGNG’s financial reports will consolidate both IGNG’s and Grapefruit’s balance sheet, statement of operation and statement of cash flows and IGNG and Grapefruit will be operated as a single company. IGNG intends to change its name to Grapefruit and to obtain a more appropriate trading symbol as soon as possible. Hereinafter the combined companies will be referred to as “Grapefruit” or the “Company.”

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds licenses to both manufacture and distribute cannabis products which were originally issued in January 2018 and is fully compliant with all applicable laws and regulations to operate its cannabis manufacturing and distribution businesses.

The company is well-focused on sourcing only the “best of the best” raw cannabis materials to create the highest quality, most-trusted and consistent recreational and medical cannabis products for its customers. Grapefruit is committed to ensuring class-leading quality by rigorously testing the purity and potency of its raw materials throughout the manufacturing process and distribution chain.

Grapefruit owns and operates its fully licensed and compliant ethanol extraction laboratory located in the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. The company’s extraction lab produces high quality, cannabis-derived distillate, also known as “honey oil,” from cannabis flower and “trim.” THC honey oil is one of base cannabis commodities which serves as the active ingredient in everything from infused edibles and tinctures/creams to the cartridges used in vapes and e-cigarettes. Honey oil often sells on the wholesale marketplace for thousands of dollars per liter, with pricing being dependent on quantity purchased, as well as other market factors such as the availability and cost of the underlying flowers and/or trim.

Grapefruit began its extraction operations in May 2019. Plans are in place to expand its honey oil production through the purchase of additional distillation equipment, which is expected to significantly increase the company’s production capacity by the fourth quarter of 2019. Grapefruit’s extraction lab is fully scalable and expansion will be built-out on a two-acre lot owned by Grapefruit at the Coachillin’ site adjacent to its current manufacturing and distribution operation.

Grapefruit selected the City of Desert Hot Springs for its cannabis extraction laboratory, because the city has created a friendly business environment for cannabis-based manufacturers, including incentives like the absence of taxes on cannabis oil production revenues. This affords Grapefruit a fundamental competitive market advantage over other Honey Oil producers.

The California cannabis regulatory scheme is unique in that it requires all cultivators (cannabis farms) and manufacturers (whether producing oils/distillates, infused edibles, tinctures creams or other cannabis products) to sell their products into the legal cannabis wholesale and retail markets exclusively through licensed distributors such as Grapefruit. Grapefruit initially obtained its California recreational and medicinal cannabis distribution license Jan. 4, 2018. In May 2019, Grapefruit was granted its provisional distribution license which is renewable annually, thereby cementing the regulatory foundation necessary to rapidly expand its distribution business.

Grapefruit’s distribution license affords it a twofold strategic advantage: first, to market and sell its own cannabis product lines to retailers throughout California; and second, to buy and resell bulk cannabis flowers and trim as well as all other legal cannabis products to properly licensed distributors and/or retailers throughout California.

The Coachillin’ Canna-Business Park, home to Grapefruit’s current operating facilities and adjacent two-acre parcel of land, is a 160-acre, self-contained legally mapped compound providing the Company with a fully permitted and serviced physical plant from which Grapefruit intends to establish a leading position in the booming California cannabis sector. The parcel was purchased by the Company prior to the Park’s full development, and the value of the land the Company owns has conservatively since doubled in value to over $2 million. Additional long-term benefits of the Coachillin’ compound include agricultural rates for power, which are currently $0.09 per kilowatt hour; the Park’s deep-water well that fully satisfies its need for water; and security expenses shared by all resident businesses. The Coachillin’ Park’s promoters also plan to position the Park, located only 10 miles north of rapidly growing uptown Palm Springs and less than 15 miles from the site of the Coachella and Stagecoach music festivals as a must-see canna-tourism destination.

Grapefruit’s ultimate goal is to become a vertically integrated, seed-to-sale cannabis and CBD product company serving the California market. Moreover, it plans to roll-out its product lines in other states, such as Nevada, Illinois, Oregon, Colorado and Washington. Grapefruit has plans to build a large, all-inclusive facility that will house a 50,000-square-foot-plus indoor grow canopy, a large extraction laboratory designed to extract both THC and CBD cannabinoids via non-volatile (ethanol) and volatile (butane) processes, a manufacturing space to produce Grapefruit’s vape lines and CBD products, an FDA-certified kitchen for the production of Grapefruit edibles and a distribution facility to sell all products into the entire cannabis market. The indoor grow canopy operation will be outfitted and operated to produce ultra-high-quality flowers and buds, some of which, along with the high-quality trim resulting from cleaning and maintaining the grow, will provide biomass necessary to feed the company’s extraction laboratory. Fueled by this hand cultivated biomass, Grapefruit’s lab will continuously produce pesticide and heavy metal-free world class honey oil to both serve as the active ingredient in all of Grapefruit’s branded and unbranded products and meet the projected ever-growing demand for high quality honey oil in the California market.

Grapefruit’s motto – A High You Can Trust – embodies its philosophy and ethos, reminding consumers of the company’s commitment to manufacturing, procuring and distributing only the highest quality all-natural cannabis flower, concentrates and related products that are free from pesticides, heavy metals and bacteria. Grapefruit will target its products to all recreational cannabis enthusiasts’ as continuous, consistent cannabis products. By relentlessly adhering to these policies Grapefruit intends to become the Titleist of the Cannabis industry, known for unwavering quality and consistency.

Grapefruit is managed by a team of experts possessing the experience, skill and resources required to succeed in the competitive cannabis marketplace. Founded by brothers Bradley Yourist, CEO, and Daniel Yourist, COO, Grapefruit has expanded to become a group of industry professionals sharing a passion for all things cannabis. Both the CEO & COO are attorneys licensed to practice law the State of California who possess expert cannabis licensing and regulatory expertise and experience, which will allow Grapefruit to deftly navigate the ever changing California regulatory landscape and apply for new cannabis licenses at reduced costs when necessary, rather than having to acquire licenses that are often overvalued and/or pay outside counsel to handle such matters.

Grapefruit also has its own line of cannabis-infused concentrates and edibles. Among the brands now in stores or soon to be launched are:

  • Rainbow Dreams is a new lifestyle brand designed specifically for the recreational cannabis marketplace. The Rainbow Dreams brand captures the anything goes party vibe of the 1970s by offering an array of cannabis products, such as a line of vape carts with unique cannabis strains combined with all-natural flavors for a superior no-burn experience. Rainbow Dreams fills an important niche in the marketplace as a top shelf quality product line that is competitively priced.
  • Sugar Stoned, which Grapefruit acquired in the winter of 2018, has always been a popular cannabis edibles brand which terminated operations when recreational cannabis became legal and required a license in California. Grapefruit purchased the Sugar Stoned brand in 2019 and it is now a Grapefruit portfolio brand consisting of a premium quality cannabis-infused gummy line with eight different flavors: blue raspberry, cherry, grape, peach, pineapple, sour apple, strawberry and watermelon. Grapefruit intends to expand the brand in the near future through the release of a variety of infused cookies.

Grapefruit Boulevard Investments Inc. (IGNG), closed Thursday's trading session at $0.1151, off by 7.6985%, on 162,325 volume with 38 trades. The average volume for the last 3 months is 320,569 and the stock's 52-week low/high is $0.006095/$0.358999997.

Recent News

chart

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)

The QualityStocks Daily Newsletter would like to spotlight IONIC Brands Corp. (OTC: IONKF).

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3)is a cannabis holding company supplying recreational cannabis products, with headquarters in Tacoma, Washington. The company’s cannabis products are currently sold in 685 stores across the U.S., and it is planning further expansion around the country. In addition to other states, IONIC plans to expand to at least 318 stores in California and 225 stores in Oregon by January 2020.

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in leading markets across the western United States, with current operations in Washington, Oregon, California and Nevada. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.

With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.

IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.

Elite Brand Portfolio/Acquisitions

  • IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
  • WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
  • ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
  • Vuber Technologies hardware produces the best vaporization experience on the market.
  • Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
  • Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.

IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.

Experienced Management Team

IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.

Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.

Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.

Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.

Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.

In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.

IONIC Brands Corp. (OTC: IONKF), closed Thursday's trading session at $0.0283, off by 2.4138%, on 90,874 volume with 30 trades. The average volume for the last 3 months is 284,296 and the stock's 52-week low/high is $0.0215/$0.634559988.

Recent News

chart

CloudCommerce (OTCQB: CLWD)

The QualityStocks Daily Newsletter would like to spotlight CloudCommerce (OTCQB: CLWD).

CloudCommerce’s (OTCQB: CLWD) SWARM is a proprietary, audience-driven, business-intelligence solution. An article discussing the company reads, “SWARM combines a range of disciplines — advanced data science, behavioral science, artificial intelligence and marketing research — to discover, develop and create custom audiences for any business activity (http://nnw.fm/pShU3). To view the full article, visit http://nnw.fm/Ec8GK.

CloudCommerce (OTCQB: CLWD) is a leading provider of audience-driven business intelligence and marketing solutions. Together with its wholly owned subsidiaries, CloudCommerce delivers invaluable end-to-end business intelligence and marketing solutions through a range of services and capabilities.

Flagship Solution

SWARM is an end-to-end solution that applies advanced data science, behavioral science, artificial intelligence and market research techniques to deliver powerful audience-driven business intelligence that converts opportunities into business success.

Through marketing, brand perception, customer-relationship management, human-resources management and operational logistics applications, CloudCommerce’s SWARM solution helps businesses determine who to talk to, what to say and how to motivate targeted audiences to take meaningful action.

The Market

Marketers have largely taken a blanket approach to communication. The same messages are often sent across an entire customer audience with little regard for how different groups of people communicate, build communities and develop their purchasing habits. When marketers do segment audiences, they use objective selection criteria such as income, geography, education or purchase history to deduce attitudes or intentions.

However, research shows that motivations and feelings are much more accurate at predicting behavior. The challenge for businesses is that these factors are also the hardest to gather from audience data. CloudCommerce provides that audience-intelligent data through SWARM, its proprietary behavioral-science approach to audience creation and communication. Through SWARM, CloudCommerce helps marketers identify consumer motivations and triggers in order to effectively predict and influence actions. When companies influence action, they can change opinions, gather support, motivate purchases and inspire change.

In a fast-developing global business intelligence market estimated to grow from $16.3 billion in 2016 to $34.3 billion by 2022, CloudCommerce stands apart as an innovator and true partner, able to deliver data-driven intelligence and solutions that enable its customers to strengthen their brands, deliver their messages and reach their goals.

SWARM Products

THE SWARM—Intelligent Audience Building
The core of the CloudCommerce solution – and what separates CloudCommerce from other audience data companies – is the company’s unique approach to audience building. The concept of “personas” has been around for decades, but CloudCommerce takes that concept to the next level. The SWARM was developed to identify not only who to talk to but also what to say in order to motivate target audiences to take meaningful action. Using CloudCommerce’s proprietary clustering and behavioral analysis techniques, businesses can identify target audiences and deliver messages that are more focused and efficient. CloudCommerce not only helps its client partners find the right people to talk to but also identifies the most powerful message to send.

BUZZ—Behavior-Based Market Research
Market research is evolving. Research techniques developed and used today are more sophisticated and backed by strong data science. Despite these changes, many traditional research firms have failed to innovate: small sample sizes, survey design bias, improper weighting and gut-intuition sampling are just some of the issues that plague the market-research industry. Through BUZZ, CloudCommerce has automated the market research process to provide a level of statistical depth beyond what traditional firms can offer. BUZZ offers businesses the ability to put their finger on the pulse of the marketplace in the moment. Using a wide range of internal and external data sources such as customer data, social media activity, and micro and macro trends, BUZZ deduces attitudes, emotions and opinions.

HIVE—Redefined Geographic Targeting
Conventional geographic audience targeting is outdated. Arbitrary units of location such as counties, cities, DMAs and regions were created centuries ago based on land-rights ownership. Their use in understanding people’s behavior, purchase habits and underlying values is minimal. CloudCommerce has found a much more powerful, efficient and effective way of targeting by clustering people into granular geographic tribes called HIVES. HIVES are defined by attributes such as common language (e.g., colloquialisms), shared experience and narratives (e.g., climate, history), and concentrated demography and biology (e.g., ethnicity, age). Based on the needs of its clients, CloudCommerce can completely redraw the geographic lines based on various Hive selection criteria. Using this exclusive HIVE approach, CloudCommerce clients experience more efficient and effective marketing, make more intelligent business decisions and enjoy more growth.

HONEY—Advanced Reporting and Visualization
Advanced-audience, data-analysis technologies are useless if they don’t produce simple, powerful and actionable business intelligence. HONEY comes with user-friendly reporting and visualization tools to organize and explain all of the advance-data science into a simple-to-understand format for decision makers. HONEY combines the intelligence of client CRM data with third-party consumer data and targeted market research to create a powerful foundation for any audience-intelligence solution.

Subsidiaries

Data Propria
Data Propria delivers the highest Return on Investment (“ROI”) for their customers’ digital marketing campaigns, by utilizing sophisticated data science to identify the correct universes to target relevant audiences. Their ability to understand and translate data drives every decision they make. By listening to and analyzing their customers’ data they are able to make informed decisions that positively impact their customers’ business. Data Propria leverages industry-best tools to aggregate and visualize data across multiple sources, and then their data and behavioral scientists segment and model that data to be deployed in targeted marketing campaigns. They have data analytics expertise in retail, wholesale, distribution, logistics, manufacturing, political, and several other industries.

Parscale Digital
Parscale Digital helps their customers get their message out, educate their market and tell their story. They do so creatively and effectively by deploying powerful call-to-action digital campaigns with national reach and boosting exposure and validation with coordinated advertising in print media. Parscale Digital’s fully-developed marketing plans are founded on sound research methodologies, brand audits and exploration of the competitive landscape. Whether their customer is a challenger brand, a political candidate, or a well-known household name, Parscale Digital’s strategists are skilled at leveraging data and creating campaigns that move people to make decisions.

Giles Design Bureau
Giles Design Bureau approaches branding from a “big picture” perspective, establishing a strong identity and then building on that to develop a comprehensive branding program that tells the customer’s story, and articulates what sets the customer apart from their competitors and establishes the customer in their market.

WebTegrity
WebTegrity develops commerce-focused, user-friendly digital websites and apps that elevate their customer’s marketing position and draw consumers to their products and services. Their platform-agnostic approach allows WebTegrity to architect and build solutions that are the best fit for each customer. Once the digital properties are built, their experts will help manage and protect the website or app and provide the expertise needed to scale the infrastructure needed as the customer’s business grows.

Leadership

Andrew Van Noy, CEO & Chairman of CloudCommerce Board of Directors
Andrew Van Noy has been a director of CloudCommerce since November 2012, president of the company since April 2012, and the CEO of the company since August 2012. He also served as executive vice president of CloudCommerce from November 2011 to April 2012 and vice president of Sales and Marketing of the company from May 2011 to November 2011. From January 2009 to April 2011, Van Noy served as the vice president of Sales and Marketing for PageTransformer, which provided web and software development for iPad, iPhone and Android devices. Van Noy came to CloudCommerce with experience in digital marketing, private equity and investment banking. During his years at the company, Van Noy led the efforts to rebrand and restructure the business and presided over the acquisition of a number of companies. Van Noy graduated from BYU with a Bachelor of Science degree.

Gregory Boden, CFO and Board of Directors
Gregory Boden became a director at CloudCommerce in November 2011 and in February 2013 was named corporate secretary. In April 2012, Boden was also appointed CFO. In addition, Boden is the managing partner of a private equity company. Prior to joining the CloudCommerce team, Boden managed the franchise accounting and cash application departments of Select Staffing, a nationwide staffing company and was an accountant at KPMG LLP. Boden earned his master of accountancy degree from the University of Denver.

Brad Parscale, Board of Directors
Brad Parscale creates web-marketing strategies and oversees all technical and functional aspects of these strategies. Originally from Kansas, Parscale spent five years in California before moving to San Antonio in 2004 to establish Parscale Media, a successful web-marketing firm. His 2011 partnership with Jill Giles formed Giles-Parscale Inc. In 2016, Parscale was named digital director for the Donald J. Trump presidential campaign.

Zachary Bartlett, VP of Corporate Development and Board of Directors
Zachary Bartlett has been a director of the company since July 2012 and was appointed vice president of Corporate Development in January 2018. Bartlett has also served as vice president of Communications and an independent contractor assisting with project management matters. Prior to joining CloudCommerce, Bartlett was the creative director at Crowbar Studios Inc., a graphic design and web development firm he founded in 2008. From 2004 to 2008, he held the position of art and brand consultant at Demon International, a snowboard accessories company. Bartlett earned his bachelor of fine arts degree in graphic design from Brigham Young University.

CloudCommerce (OTCQB: CLWD), closed Thursday's trading session at $0.0033, off by 10.3261%, on 648,933 volume with 13 trades. The average volume for the last 3 months is 1,017,889 and the stock's 52-week low/high is $0.0027/$0.0228.

Recent News

chart

Xalles Holdings Inc. (OTC: XALL)

The QualityStocks Daily Newsletter would like to spotlight Xalles Holdings Inc. (OTC: XALL).

Xalles Holdings (OTC: XALL), a business development company focused on the payment industry and financial technology, is targeting the worldwide account-reconciliation software market, which is projected to grow at a CAGR of more than 8.5% through 2025. To view the full article, visit http://ccw.fm/MpA5F.

Xalles Holdings Inc. (OTC: XALL) is a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions. The company actively seeks acquisition targets with strong management teams and business models, large total attainable markets, and lucrative exit opportunities in which to invest and accelerate growth.

Operations

The common element to all acquired entities and projects is a business model that involves setting up a payment or financial transaction “toll gate,” thereby creating a recurring revenue stream.

Xalles’ business plan focuses on consumer, business and government-oriented payment and financial reconciliation transactions. Combining the blockchain decentralized financial ledger platform with the company’s existing X2X transaction reconciliation system design, Xalles is building technology that supports payment audits, exchanges, and new business models and opportunities worldwide. Xalles will launch new services card and mobile payment and rewards systems, and will expand the technology offerings for referral marketing and e-commerce engines.

Subsidiaries
All current subsidiaries are wholly owned

  • Xalles Holdings
    Raise capital for fintech accelerator program acquisitions, provide management, administrative, finance and marketing support to all subsidiary companies
  • Xalles Capital
    Management support of investment consortiums, direct investment into funds or projects, and management of investments
  • Xalles Limited
    Design and market new X2X solutions; acquire U.S Government transportation post-payment audit business through GSA schedule and expand to non-transportation payment auditing
  • Xalles Technology
    Technical development of the X2X blockchain systems
  • Xalles Financial Services
    Consumer and small business financial service offerings
  • Co-Owners Rewards
    Stock-based rewards system for payments cards and financial services
  • Amazing Living Enterprises
    Affiliate program and e-commerce platform for enhancing financial lives
  • Global Savings Network
    Not-for-profit fundraising system with consumer discounts at local merchants

X2X Solutions

Xalles provides payment and financial transaction management solutions through the company’s proprietary blockchain-based X2X technology. The X2X solution includes the Investment and Financing System (IFS), which supports complex investment structures, assists international investment consortia, and provides links to Xalles’ Financial Transaction Reconciliation (FTR) solution. FTR supports complex financial ecosystems, making it easier for parties to exchange products, services, grants and government incentives, and assists “Exchange Managers” with liquidity and auditability. X2X also supports the Xalles pre- and post-payment auditing services.

Advancements in 2019

  • Co-Owners Rewards subsidiary is working to launch a general purpose reloadable prepaid payment card with a stock rewards program.
  • Previously announced LYC Mortgage acquisition will create a structure that will dramatically increase revenues in 2020 with new mortgage business portfolios.
  • Xalles Financial Services expects to launch the Cryptocurrency Trading Engine and acquire multiple cryptocurrency asset portfolios to drive increases in value through the trading engine.

“The structure and growth plan for the company contains a balance of diversity and synergy so that we can effectively use limited resources to obtain the best results. We will see the culmination of the fundraising efforts, acquisitions and organic growth in the second half of 2019 put us on the path to tremendous growth in 2020.”

– Xalles CEO Thomas Nash (http://nnw.fm/rU6iT)

Xalles Holdings Inc. (OTC: XALL), closed Thursday's trading session at $0.00314, off by 7.6471%, on 217,306 volume with 8 trades. The average volume for the last 3 months is 2,690,745 and the stock's 52-week low/high is $0.0013/$0.021029999.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.